RFK is required for 4, 4’-dimethoxychalcone mediated neuroprotection in Parkinson’s disease (PD) mouse models, and reduction of RFK may be related to PD pathogenesis (Gong et al. 2021). Here, RFK is linked to Parkinson disease.